Cargando…
Antibody producing human-human hybridomas. II. Derivation and characterization of an antibody specific for human leukemia cells
Human-human hybridoma technology was used to immortalize human B lymphocytes from patients with acute myeloid leukemia (AML) to study the antigenic repertoire of the humoral immune response against the patients' own leukemia cells and against leukemic cells from other patients. Nine fusions wer...
| Formato: | Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
The Rockefeller University Press
1984
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2187227/ https://www.ncbi.nlm.nih.gov/pubmed/6582214 |